(new-borns) can produce hepatotoxic metabolites (e.g. NAPQI), but the lower activity of cytochrome P450 in neonates and higher glutathione stores may explain the low incidence of acetaminophen-induced hepatotoxicity seen in
(new-borns) can produce hepatotoxic metabolites (e.g. NAPQI), but the lower activity of cytochrome P450 in neonates and higher glutathione stores may explain the low incidence of acetaminophen-induced hepatotoxicity seen in